Ardelyx Highlights Presentation Of Data Supporting Clinical Utility Of Tenapanor At ASN’s Kidney Week 2021
Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company focused on the discovery, development, and commercialization of innovative first-in-class medicines to improve treatment for people with kidney and cardiorenal